GLP-1, or glucagon-like peptide-1, plays a crucial role in enhancing insulin sensitivity and glucose absorption in the body. This discussion highlights how GLP-1 agonists are developed as effective treatments for type 2 diabetes, emphasizing the importance of managing continuously high glucose levels rather than just worrying about spikes. The insights reveal the significance of these drugs in combating metabolic syndrome and improving overall metabolic health.
